Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 1998

View Archived Issues

Novel PTK-related technology from Genentech and collaborators

Preclinical pharmacology of ebselen described in depth

ProCyte reports results from U.K. leg ulcer study

Calanolide A well tolerated in phase I trials

Tiazac approved for angina in U.S.

Warner-Lambert presents SAR for potent, nonpeptide HIV protease inhibitor at AIDS conference

Avita gel can now be launched in U.S.

Genetic basis for RP described

Favorable clinical safety, pharmacokinetics and anti-CMV activity reported for 1263W94

Concrete terms of Receptagen-Scitech Genetics merger announced

Gene-based breast cancer test launched in U.S.

Salivary peptide fragment may be useful for oral candidiasis

Algos initiates FDA approval process for MorphiDex

Janssen obtains worldwide license to develop and market norastemizole

E.U. gives stamp of approval to Roche acquisition of Corange

Cytel and Baxter extend xenotransplantation agreement

Early clinical results support potential of ABT-378/ritonavir combination

Another name change for BioDx

Biomet-Merck orthopedic joint venture

Multiple-dose phase I trial of FP-21399 in HIV discussed at AIDS conference

New anti-PCP agent is more potent than pentamidine

PNU-140690: clinical pharmacokinetics and safety after single and multiple doses

Seragen fusion toxin will get priority review

Penederm and Alpharma enter marketing agreement

NIF is neuroprotective in rat model of ischemia

Pharmacokinetics and drug interactions for Fortovase

FddA demonstrates anti-HIV activity at well-tolerated doses in phase I trial

Zestril introduced for new indication in U.K.

CardioGenesis receives EU approval to market cardiovascular device

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...